| CoR | Nuclear Receptor Co-Repressor |
| COVID-19 | CoronaVirus Disease 2019 |
| DAD | Deacetylase-Activating Domain |
| EMT | Epithelial-to-Mesenchymal Transition |
| FDA | Food and Drug Administration |
| FK228 | Romidepsin |
| FPKM | Fragments Per Kilobase of transcript length per Million of mapped reads |
| GTEx | Genotype-Tissue Expression project |
| HAT | Histone Acetyltransferase |
| HCC | Hepatocellular Carcinoma |
| HDAC | Histone Deacetylase |
| HDACi | Histone Deacetylase inhibitor |
| IFN | Interferon |
| LBH589 | Panobinostat |
| LSD1 | Lysine Demethylase 1 |
| MEF2 | Myocyte Enhancer Factor 2 |
| NES | Nuclear Exporting Signal |
| MGCD0103 | Mocetinostat |
| MiDac | Mitotic Deacetylase Complex |
| MS-275 | Entinostat |
| NBL | Neuroblastoma |
| NLS | Nuclear Localization Sequence |
| NR | Nuclear Receptor |
| NuRD | Nucleosome Remodeling Deacetylase |
| PTM | Post-Translational Modification |
| PXD101 | Belinostat |
| RD | Repression Domain |
| REST | RE1 Silencing Transcription Factor |
| SAHA | Vorinostat |
| SARS-CoV-2 | Severe Acute Respiratory Syndrome CoronaVirus 2 |
| SIRT | Sirtuins |
| SMN | Survival of MotoNeurons |
| TCGA | The Cancer Genome Atlas |
| TF | Transcription Factor |
| TNBS | Triple Negative Breast Cancer |
| TSA | Thrichostatin A |
| TSS | Transcription Start Site |
| VPA | Valproic Acid |